Menten AI Employee Directory
Biotechnology ResearchCalifornia, United States11-50 Employees
Menten AI is a biotechnology research company based in San Francisco, California, that applies generative AI to the design of cyclic peptide therapeutics. Its MAUD 1.0 platform enables the rapid creation of macrocycles with properties compatible with oral administration and cellular uptake. The company focuses on targets that are not accessible to traditional small molecules or biologics. Menten AI collaborates with major pharmaceutical developers to accelerate preclinical discovery, including partnerships with Bristol Myers Squibb. In January 2026, the company launched MAUD 1.0, signaling a new phase in its AI-driven approach to cyclic peptide medicines.